These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 19164226

  • 1. Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients.
    Roy FN, Beaulieu S, Boucher L, Bourdeau I, Cohade C.
    J Nucl Med; 2009 Feb; 50(2):178-83. PubMed ID: 19164226
    [Abstract] [Full Text] [Related]

  • 2. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT.
    Büsing KA, Schönberg SO, Brade J, Wasser K.
    Nucl Med Biol; 2013 Feb; 40(2):206-13. PubMed ID: 23228852
    [Abstract] [Full Text] [Related]

  • 3. Proposal for an optimized protocol for intravenous administration of insulin in diabetic patients undergoing (18)F-FDG PET/CT.
    Caobelli F, Pizzocaro C, Paghera B, Guerra UP.
    Nucl Med Commun; 2013 Mar; 34(3):271-5. PubMed ID: 23250295
    [Abstract] [Full Text] [Related]

  • 4. Optimization of whole-body positron emission tomography imaging by using delayed 2-deoxy-2-[F-18]fluoro-D: -glucose Injection following I.V. Insulin in diabetic patients.
    Turcotte E, Leblanc M, Carpentier A, Bénard F.
    Mol Imaging Biol; 2006 Mar; 8(6):348-54. PubMed ID: 17053859
    [Abstract] [Full Text] [Related]

  • 5. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
    Chen W, Cloughesy T, Kamdar N, Satyamurthy N, Bergsneider M, Liau L, Mischel P, Czernin J, Phelps ME, Silverman DH.
    J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial on the optimization of 18F-FDG myocardial uptake suppression: implications for vulnerable coronary plaque imaging.
    Demeure F, Hanin FX, Bol A, Vincent MF, Pouleur AC, Gerber B, Pasquet A, Jamar F, Vanoverschelde JL, Vancraeynest D.
    J Nucl Med; 2014 Oct; 55(10):1629-35. PubMed ID: 25082852
    [Abstract] [Full Text] [Related]

  • 7. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.
    Yun M, Choi HS, Yoo E, Bong JK, Ryu YH, Lee JD.
    J Nucl Med; 2005 Jun; 46(6):953-7. PubMed ID: 15937305
    [Abstract] [Full Text] [Related]

  • 8. Ultrashort-acting insulin may improve on 18F-FDG PET/CT image quality in patients with uncontrolled diabetic mellitus.
    Song HS, Yoon JK, Lee SJ, Yoon SH, Jo KS, An YS.
    Nucl Med Commun; 2013 Jun; 34(6):527-32. PubMed ID: 23511925
    [Abstract] [Full Text] [Related]

  • 9. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
    Hashimoto Y, Tsujikawa T, Kondo C, Maki M, Momose M, Nagai A, Ohnuki T, Nishikawa T, Kusakabe K.
    J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
    [Abstract] [Full Text] [Related]

  • 10. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E, Leva L, Matheoud R, Sacchetti G, Secco C, Gandolfo P, Brambilla M, Sambuceti G.
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [Abstract] [Full Text] [Related]

  • 11. Effects of varying serum glucose levels on 18F-FDG biodistribution.
    Webb RL, Landau E, Klein D, DiPoce J, Volkin D, Belman J, Voutsinas N, Brenner A.
    Nucl Med Commun; 2015 Jul; 36(7):717-21. PubMed ID: 25888357
    [Abstract] [Full Text] [Related]

  • 12. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
    Delbeke D, Rose DM, Chapman WC, Pinson CW, Wright JK, Beauchamp RD, Shyr Y, Leach SD.
    J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
    [Abstract] [Full Text] [Related]

  • 13. Altered biodistribution of FDG in patients with type-2 diabetes mellitus.
    Ozguven MA, Karacalioglu AO, Ince S, Emer MO.
    Ann Nucl Med; 2014 Jul; 28(6):505-11. PubMed ID: 24652347
    [Abstract] [Full Text] [Related]

  • 14. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
    Hustinx R, Lemaire C, Jerusalem G, Moreau P, Cataldo D, Duysinx B, Aerts J, Fassotte MF, Foidart J, Luxen A.
    J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
    [Abstract] [Full Text] [Related]

  • 15. [Correlation of 3'-deoxy-3'-18F-fluorothymidine uptake to cell proliferation in lung carcinoma xenografts].
    Liu X, Zhou NK, Zhang JM, Liang ZY, Zheng X.
    Ai Zheng; 2006 Dec; 25(12):1512-6. PubMed ID: 17166377
    [Abstract] [Full Text] [Related]

  • 16. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
    Cohade C, Osman M, Pannu HK, Wahl RL.
    J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
    [Abstract] [Full Text] [Related]

  • 17. Optimizing experimental protocols for quantitative behavioral imaging with 18F-FDG in rodents.
    Schiffer WK, Mirrione MM, Dewey SL.
    J Nucl Med; 2007 Feb; 48(2):277-87. PubMed ID: 17268026
    [Abstract] [Full Text] [Related]

  • 18. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values.
    Abele JT, Fung CI.
    Radiology; 2010 Mar; 254(3):917-24. PubMed ID: 20177102
    [Abstract] [Full Text] [Related]

  • 19. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes.
    Zhuang H, Pourdehnad M, Lambright ES, Yamamoto AJ, Lanuti M, Li P, Mozley PD, Rossman MD, Albelda SM, Alavi A.
    J Nucl Med; 2001 Sep; 42(9):1412-7. PubMed ID: 11535734
    [Abstract] [Full Text] [Related]

  • 20. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
    Nuutinen J, Minn H, Bergman J, Haaparanta M, Ruotasalainen U, Laine H, Knuuti J.
    Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.